Passage BIO, Inc. License Agreements
3 Contracts & Agreements
- Exclusive License Agreement (PBML04), dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Filed With SEC on November 13, 2024)
- Exclusive License Agreement (PBKR03), dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Filed With SEC on November 13, 2024)
- Exclusive License Agreement (PBGM01), dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Filed With SEC on November 13, 2024)
